Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 714 t. | 521 t. | 6.7 mio. | 6 mio. | 3 | |
CVR: 43340743
Secondary names: Ketlace ApS, Mmimetika Biosciences ApS, Mmimetika Ingredients ApS
Previous names: KetLace Biosciences ApS
Compared to 1.002 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Jakob Helding Rasmussen joined the board
Peter Dybdahl Ollendorff Hede left the board
Jakob Helding Rasmussen left the board
Karan Sarin joined as ADM. DIR.
Jan Mousing left as director
REVISION OG RÅDGIVNINGSGRUPPEN GODKENDT REVISIONSPARTNERSELSKAB appointed as auditor
Jakob Helding Rasmussen joined the board
Companies in the same industry and area
CVR 37724157
CVR 43574736
CVR 46274199
CVR 46260643
CVR 10403782
companydata.dk